Managers / Q2 2019 · view latest →
One68 Global Capital, LLC
CIK 0001755535 · 135 WEST 50TH STREET, SUITE 200, NEW YORK, NY, 10020 · 212-331-6783
Summary
One68 Global Capital, LLC reported $79M in U.S.-listed holdings across 18 positions for Q2 2019.
The portfolio is heavily concentrated: Red Hat alone accounts for 26.5% of reported value.
Compared with Q1 2019, the fund opened 9 new positions and exited 9.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 99.2% · $79M
- ADR · 0.7% · $593,000
- Other · 0.0% · $8,000
Quarter-over-Quarter Changes full breakdown →
vs Q1 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ANADARKO PETE CORP | NEW | +272.7K | 272.7K | +$19M | $19M |
| ARRAY BIOPHARMA INC | NEW | +85.0K | 85.0K | +$4M | $4M |
| ZAYO GROUP HLDGS INC | NEW | +92.0K | 92.0K | +$3M | $3M |
| FNSRFINISAR CORP | NEW | +79.8K | 79.8K | +$2M | $2M |
| CRAYCRAY INC | NEW | +47.0K | 47.0K | +$2M | $2M |
| VERSUM MATLS INC | NEW | +25.6K | 25.6K | +$1M | $1M |
| CNCCENTENE CORP DEL | NEW | +23.7K | 23.7K | +$1M | $1M |
| AVAYA HLDGS CORP | NEW | +21.5K | 21.5K | +$256,000 | $256,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2019
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | RED HAT INC | COM | 26.47% | $21M | 111.9K |
| 2 | ANADARKO PETE CORP | COM | 24.24% | $19M | 272.7K |
| 3 | CELGCELGENE CORPhistory → | COM | 16.65% | $13M | 143.0K |
| 4 | SPARK THERAPEUTICS INC | COM | 7.74% | $6M | 60.0K |
| 5 | ARRAY BIOPHARMA INC | COM | 4.96% | $4M | 85.0K |
| 6 | FDCFIRST DATA CORP NEWhistory → | COM CL A | 4.92% | $4M | 144.3K |
| 7 | ZAYO GROUP HLDGS INC | COM | 3.81% | $3M | 92.0K |
| 8 | FNSRFINISAR CORPhistory → | COM NEW | 2.30% | $2M | 79.8K |
| 9 | CRAYCRAY INChistory → | COM NEW | 2.06% | $2M | 47.0K |
| 10 | ABMABM INDS INChistory → | COM | 1.83% | $1M | 36.5K |
| 11 | VERSUM MATLS INC | COM | 1.66% | $1M | 25.6K |
| 12 | CNCCENTENE CORP DELhistory → | COM | 1.56% | $1M | 23.7K |
| 13 | GNFTYGENFIT S A | ADS | 0.75% | $593,000 | 30.0K |
| 14 | AVAYA HLDGS CORP | COM | 0.32% | $256,000 | 21.5K |
| 15 | LKSDQLSC COMMUNICATIONS INC | COM | 0.31% | $243,000 | 66.2K |
| 16 | MARKER THERAPEUTICS INC | COM | 0.30% | $238,000 | 30.0K |
| 17 | GNWGENWORTH FINL INC | COM CL A | 0.09% | $75,000 | 20.3K |
| 18 | ALTA MESA RES INC | *W EXP 03/28/202 | 0.01% | $8,000 | 54.9K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $31M | 40 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $8M | 35 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $6M | 20 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $0 | 1 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $204M | 90 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $188M | 98 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $0 | 1 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $16M | 28 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $70M | 57 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $36M | 25 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $38M | 39 | May 18, 2021 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2020 | $50M | 119 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $38M | 39 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $27M | 21 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $10M | 10 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $46M | 78 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $44M | 14 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $79M | 18 | Aug 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $33M | 18 | May 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $22M | 12 | Feb 6, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.